戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tors, alpha1-proteinase inhibitor and alpha1-antichymotrypsin.
2 ytokine signaling-3, lipocalin-2, and alpha1-antichymotrypsin.
3 to detect genes for alpha(1)-antitrypsin and antichymotrypsin.
4 ing of the product identified it as alpha(1)-antichymotrypsin.
5 ed for variants in coding regions of alpha-1-antichymotrypsin.
6 complex with the protease inhibitor, alpha-1-antichymotrypsin.
7  with the serine protease inhibitor alpha(1)-antichymotrypsin.(1,2) However, it is unknown whether th
8 raised concentrations (16% higher for alpha1-antichymotrypsin, 18% for alpha1-acid-glycoprotein, 25%
9 GR/MYOC, a serine protease inhibitor (alpha1-antichymotrypsin), a neuroprotective factor (pigment epi
10 n G can also be completely blocked by alpha1 antichymotrypsin, a specific inhibitor of chymotrypsin-l
11                                       alpha1-Antichymotrypsin (AACT) is a major component of the amyl
12 rticosteroid-binding globulin (CBG), alpha 1-antichymotrypsin (AACT), and protein C inhibitor (PCI) a
13 rations of two acute-phase proteins, alpha 1-antichymotrypsin (ACT) and alpha 2-macroglobulin (MAC),
14 ition of human chymase by the serpins alpha1-antichymotrypsin (ACT) and alpha1-proteinase inhibitor (
15 ursor protein (APP), A beta protein, alpha 1-antichymotrypsin (ACT) and ubiquitin.
16  based on immunochemical detection of alpha1-antichymotrypsin (ACT) in amyloid plaques from the hippo
17                                      alpha-1-Antichymotrypsin (ACT) is present in neuritic plaques in
18 cs identified significant changes in alpha-1-antichymotrypsin (ACT) levels during LVAD support.
19  14q32.1 allow a single gene encoding alpha1-antichymotrypsin (ACT) to be expressed in astrocytes and
20 logue HTJ1 and its interaction with alpha(1)-antichymotrypsin (ACT), a member of the serine proteinas
21                         Additionally, alpha1-antichymotrypsin (ACT), a serpin family inhibitor tightl
22 astase (HNE) could be transferred to alpha-1-antichymotrypsin (ACT), a serpin that does not inhibit H
23                                     Alpha(1)-antichymotrypsin (ACT), an acute-phase inflammatory prot
24 agment deposition, reactive gliosis, alpha-1-antichymotrypsin (ACT), and apolipoprotein E (APOE).
25 hat are known to interact with Abeta: alpha1-antichymotrypsin (ACT), interleukin-1beta (IL-1beta), S1
26 rine proteinase inhibitor (serpin), alpha(1)-antichymotrypsin (ACT), is encoded by a gene located wit
27 erine proteinase inhibitor (serpin) alpha(1)-antichymotrypsin (ACT), which is the dominant form of PS
28 chromosome 14, presenilin 1 (PS1) and alpha1-antichymotrypsin (ACT), with the risk of sporadic Alzhei
29 ein is the serine protease inhibitor alpha-1-antichymotrypsin (ACT).
30 Chtr within the complex that Chtr forms with antichymotrypsin (ACT).
31 cently we presented evidence that the serpin antichymotrypsin (ACT, I) reacts with the serine protein
32 rams/L), and the acute-phase protein alpha 1-antichymotrypsin (ACT; 0.06 g/L).
33              Then we determined that alpha-1-antichymotrypsin (alpha-ACT), an acute-phase factor abun
34  between granzyme M and the serpins alpha(1)-antichymotrypsin, alpha(1)-proteinase inhibitor, and pro
35  liver, including alpha1-antitrypsin, alpha1-antichymotrypsin, alpha-fetal protein, ceruloplasmin, IG
36 H dependence of the conversion of the alpha1-antichymotrypsin.alpha-chymotrypsin encounter complex, E
37 receptor 2 (sTNFR2) (0.354, p<0.005), alpha1-antichymotrypsin (alpha1-ACT) (1.217, p<0.005), IL-1beta
38                                       alpha1-Antichymotrypsin (alpha1-ACT), a member of the serpin fa
39 xpression of SERPINA3, which encodes alpha 1-antichymotrypsin (alpha1ACT).
40 und by protease inhibitors, primarily alpha1-antichymotrypsin, although a fraction is inactivated in
41 tified as the C-terminal fragment of alpha-1 antichymotrypsin and a 28 kDa protein was determined as
42 lerated by seeding with polymers of alpha(1)-antichymotrypsin and a complex of alpha(1)-antichymotryp
43 d induces transcription through the alpha(1)-antichymotrypsin and C-reactive protein promoter.
44 lobin, but stimulates production of alpha(1)-antichymotrypsin and induces transcription through the a
45  response modifier A, and the human serpins, antichymotrypsin and squamous cell carcinoma antigen 1 (
46 otects cathepsin G from inhibition by alpha1-antichymotrypsin and squamous cell carcinoma antigen 2 a
47 the distance between residue P1' in alpha(1)-antichymotrypsin and the amino terminus of chymotrypsin
48 o be alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, and alpha(2)-macroglobulin.
49 hibitors alpha1-proteinase inhibitor, alpha1-antichymotrypsin, and alpha2-macroglobulin function as c
50 ions of antithrombin, C1 inhibitor, alpha(1)-antichymotrypsin, and heparin cofactor II cause a simila
51 etory leukocyte protease inhibitor, alpha(1)-antichymotrypsin, and monocyte-neutrophil elastase inhib
52 her proteins (such as antithrombin, alpha(1)-antichymotrypsin, and plasminogen activator inhibitor-1)
53 , cyclin D3, tissue transglutaminase, alpha1-antichymotrypsin, and STAT1), which have not previously
54 rongly for desmin, alphaB-crystallin, alpha1-antichymotrypsin, and ubiquitin and variably for gelsoli
55 alphaB-crystallin, SLIM1, gelsolin, alpha(1)-antichymotrypsin, and ubiquitin.
56                             Together alpha-1 antichymotrypsin, Apo A1, and the unidentified 5191 Da p
57 protease inhibitors alpha(1)-antitrypsin and antichymotrypsin are present in human milk, but little i
58 esults suggest that alpha(1)-antitrypsin and antichymotrypsin are produced by the mammary gland and a
59 t derivatives of cysteine variants of alpha1-antichymotrypsin at the P11 and P13 residues.
60 , alpha(1)-acid glycoprotein (AGP), alpha(1)-antichymotrypsin, C-reactive protein (CRP), haptoglobin,
61 e proteins (alpha1-acid-glycoprotein, alpha1-antichymotrypsin, C-reactive protein, or serum amyloid A
62  prostate specific antigen (PSA), PSA-alpha1-antichymotrypsin, carcinoembryonic antigen and mucin-1,
63 h endopin 1 possesses homology with alpha(1)-antichymotrypsin, chymotrypsin was not inhibited.
64 d free (f) PSA and PSA complexed to alpha(1)-antichymotrypsin (complexed PSA).
65                     Alpha(1)-antitrypsin and antichymotrypsin concentrations were high in early milk
66                     alpha(1)-Antitrypsin and antichymotrypsin concentrations were measured in milk sa
67 mbin, beta amyloid precursor protein, alpha1-antichymotrypsin, cystic fibrosis transmembrane conducta
68 psin with a fluorescent derivative of alpha1-antichymotrypsin (derivatized at position P7 of the reac
69 active site (Leu-358) of the serpin alpha(1)-antichymotrypsin either one residue closer (P2) or furth
70               Coagulation factor XI, alpha-1-antichymotrypsin, ficolin-2, 14-3-3 protein, and galecti
71  The recombinant PSA was inhibited by alpha1-antichymotrypsin, forming an equimolar complex with a mo
72          We show here that wildtype alpha(1)-antichymotrypsin forms polymers between the reactive cen
73 whether the increased expression of alpha(1)-antichymotrypsin found in AD brains counteracts or contr
74 ic protein gene(3) to express human alpha(1)-antichymotrypsin (hACT) in astrocytes of transgenic mice
75           The mean concentration of alpha(1)-antichymotrypsin in human plasma is 7 micrometer.
76 y be important in the deposition of alpha(1)-antichymotrypsin in the plaques of Alzheimer's disease.
77 on, we report the crystal structure of A349R antichymotrypsin in the reactive loop cleaved state at 2
78              At this concentration, alpha(1)-antichymotrypsin inhibits both macrophage enzymes.
79                                     alpha(1)-Antichymotrypsin is a member of the serine proteinase in
80                                     Alpha(1)-antichymotrypsin is an acute phase plasma protein and a
81                                    An alpha1-antichymotrypsin-like serpin has been implicated in Alzh
82 n hypothesized that alpha(1)-antitrypsin and antichymotrypsin may modulate digestion in the infant gu
83 ary gland expresses alpha(1)-antitrypsin and antichymotrypsin, measured alpha(1)-antitrypsin and anti
84  but not with reactive loop cleaved alpha(1)-antichymotrypsin or with polymers of other members of th
85 given cathepsin G/chymase inhibitors (alpha1-antichymotrypsin or Z-Gly-Leu-Phe-CH(2)Cl), were resista
86                       Sonication of alpha(1)-antichymotrypsin polymers markedly increased the efficac
87 he structures of native ovalbumin and native antichymotrypsin, suggest that heparin may activate anti
88 we did not correlate any variants of alpha-1-antichymotrypsin, the human homologue of Spi2a, with acu
89 motrypsin, measured alpha(1)-antitrypsin and antichymotrypsin throughout lactation, assessed the resi
90 disassembly of myocardial proteins (alpha(1)-antichymotrypsin, ubiquitin, and gelsolin); (3) genes in
91 formation from alpha-chymotrypsin and alpha1-antichymotrypsin using two approaches: first, by stopped
92                                     alpha(1)-Antichymotrypsin variants were produced by mutation with
93                                       Alpha1-antichymotrypsin was a markedly ineffective inhibitor of
94 Abeta of another acute phase protein, alpha1-antichymotrypsin, was not active in preventing fibril fo
95                    All APPs, except alpha(1)-antichymotrypsin, were significantly correlated with spl
96 so is inactivated more effectively by alpha1-antichymotrypsin, which features P1 Leu in the reactive
97 e inhibitors alpha-1-antitrypsin and alpha-1-antichymotrypsin, which may function as antimicrobials a
98 )-antichymotrypsin and a complex of alpha(1)-antichymotrypsin with an exogenous reactive loop peptide
99 other isoforms of endopins related to alpha1-antichymotrypsin, yet endopin 2C differs in its target p